India's drug regulator has stepped up monitoring of unauthorised sale and promotion of GLP-1-based weight loss drugs. Acting on concerns over their easy availability, authorities inspected 49 entities, including online pharmacy warehouses, wholesalers, retailers, and wellness clinics. "Misuse of weight loss drugs without clinical oversight can lead to severe health complications," government said.